These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 11519142

  • 1. [Function of monoamine neurotransmitter transporters].
    Sasa M.
    Nihon Rinsho; 2001 Aug; 59(8):1457-64. PubMed ID: 11519142
    [Abstract] [Full Text] [Related]

  • 2. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
    Wall SC, Gu H, Rudnick G.
    Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Pharmacology of monoamine neurotransmitter transporters].
    Dohi T, Kitayama S, Kumagai K, Hashimoto W, Morita K.
    Nihon Yakurigaku Zasshi; 2002 Nov; 120(5):315-26. PubMed ID: 12491807
    [Abstract] [Full Text] [Related]

  • 5. Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies.
    Bottalico B, Larsson I, Brodszki J, Hernandez-Andrade E, Casslén B, Marsál K, Hansson SR.
    Placenta; 2004 Jul; 25(6):518-29. PubMed ID: 15135235
    [Abstract] [Full Text] [Related]

  • 6. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
    Zhou J, Zhang A, Kläss T, Johnson KM, Wang CZ, Ye YP, Kozikowski AP.
    J Med Chem; 2003 May 08; 46(10):1997-2007. PubMed ID: 12723962
    [Abstract] [Full Text] [Related]

  • 7. Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system.
    Hoffman BJ, Hansson SR, Mezey E, Palkovits M.
    Front Neuroendocrinol; 1998 Jul 08; 19(3):187-231. PubMed ID: 9665836
    [Abstract] [Full Text] [Related]

  • 8. Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine.
    Kolhatkar RB, Ghorai SK, George C, Reith ME, Dutta AK.
    J Med Chem; 2003 May 22; 46(11):2205-15. PubMed ID: 12747792
    [Abstract] [Full Text] [Related]

  • 9. The role of membrane and vesicular monoamine transporters in the neurotoxic and hypothermic effects of 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH(2)-MPTP).
    Numis AL, Unger EL, Sheridan DL, Chisnell AC, Andrews AM.
    Mol Pharmacol; 2004 Sep 22; 66(3):718-27. PubMed ID: 15322265
    [Abstract] [Full Text] [Related]

  • 10. Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants.
    Buck KJ, Amara SG.
    Mol Pharmacol; 1995 Dec 22; 48(6):1030-7. PubMed ID: 8848002
    [Abstract] [Full Text] [Related]

  • 11. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter.
    Pifl C, Drobny H, Reither H, Hornykiewicz O, Singer EA.
    Mol Pharmacol; 1995 Feb 22; 47(2):368-73. PubMed ID: 7870046
    [Abstract] [Full Text] [Related]

  • 12. Catecholamine reuptake and storage. Overview.
    Bönisch H, Eiden L.
    Adv Pharmacol; 1998 Feb 22; 42():149-64. PubMed ID: 9327868
    [No Abstract] [Full Text] [Related]

  • 13. Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters.
    Miller DK, Crooks PA, Zheng G, Grinevich VP, Norrholm SD, Dwoskin LP.
    J Pharmacol Exp Ther; 2004 Sep 22; 310(3):1035-45. PubMed ID: 15121762
    [Abstract] [Full Text] [Related]

  • 14. Phosphorylation and regulation of psychostimulant-sensitive neurotransmitter transporters.
    Vaughan RA.
    J Pharmacol Exp Ther; 2004 Jul 22; 310(1):1-7. PubMed ID: 15064332
    [Abstract] [Full Text] [Related]

  • 15. Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter.
    Barker EL, Blakely RD.
    Mol Pharmacol; 1996 Oct 22; 50(4):957-65. PubMed ID: 8863842
    [Abstract] [Full Text] [Related]

  • 16. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
    Suzuki M, Desmond TJ, Albin RL, Frey KA.
    Synapse; 2001 Sep 15; 41(4):329-36. PubMed ID: 11494403
    [Abstract] [Full Text] [Related]

  • 17. Expression cloning of a serotonin transporter: a new way to study antidepressant drugs.
    Hoffman BJ.
    Pharmacopsychiatry; 1994 Jan 15; 27(1):16-22. PubMed ID: 8159777
    [Abstract] [Full Text] [Related]

  • 18. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR, Kuszpit K, Sherman P.
    Synapse; 2000 Mar 15; 35(4):250-5. PubMed ID: 10657034
    [Abstract] [Full Text] [Related]

  • 19. Ancestry of neuronal monoamine transporters in the Metazoa.
    Caveney S, Cladman W, Verellen L, Donly C.
    J Exp Biol; 2006 Dec 15; 209(Pt 24):4858-68. PubMed ID: 17142674
    [Abstract] [Full Text] [Related]

  • 20. Beyond monoamine-based therapies: clues to new approaches.
    Skolnick P.
    J Clin Psychiatry; 2002 Dec 15; 63 Suppl 2():19-23. PubMed ID: 15453010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.